Jnana Therapeutics Appoints Joanne Kotz to Chief Executive Post

Xconomy Boston — 

Joanne Kotz has been named CEO of Jnana Therapeutics. Kotz, a co-founder of Jnana, had been president of the Boston-based company since last December, when it raised $50 million in Series A financing. Jnana is researching drugs that target solute carrier transporters, which are proteins that move substances across cellular membranes.